Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) Cash per Share: ¥1.33 (As of Jun. 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd SHSE:600613

49 GF Score

Price ¥9.09

GF Value ¥5.66

Valuation Significantly Overvalued

5 Warning Signs

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Shanghai Shenqi Pharmaceutical Investment Management Co Cash per Share?

Shanghai Shenqi Pharmaceutical Investment Management Co SHSE:600613 -9.46% 49 Cash per Share is ¥1.33 as of Jun. 2026. GuruFocus rates SHSE:600613 with a GF Score™ of 49/100 and a GF Value™ of ¥5.66 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Shanghai Shenqi Pharmaceutical Investment Management Co's Cash per Share for the quarter that ended in Jun. 2026 was ¥1.33.

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Shanghai Shenqi Pharmaceutical Investment Management Co Cash per Share Related Terms

Shanghai Shenqi Pharmaceutical Investment Management Co Cash per Share Historical Data

* Premium members only.

The historical data trend for Shanghai Shenqi Pharmaceutical Investment Management Co's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Shenqi Pharmaceutical Investment Management Co Cash per Share Chart

Shanghai Shenqi Pharmaceutical Investment Management Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Cash per Share

Get a 7-Day Free Trial

0.93

1.23

1.38

1.50

1.32

Shanghai Shenqi Pharmaceutical Investment Management Co Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26	Jun26
Cash per Share	Get a 7-Day Free Trial															1.35	1.54	1.32	1.34	1.33

49GF Score

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd SHSE:600613

Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

Shanghai Shenqi Pharmaceutical Investment Management Co Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Shanghai Shenqi Pharmaceutical Investment Management Co's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	704.489	/	534
	=	1.32

Shanghai Shenqi Pharmaceutical Investment Management Co's Cash per Share for the quarter that ended in Jun. 2026 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	708.286	/	534
	=	1.33

Frequently Asked Questions Learn more about Cash per Share →

What does a Cash per Share of ¥1.33 mean?

Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) has a Cash per Share of ¥1.33 as of Jun. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Shanghai Shenqi Pharmaceutical Investment Management Co and its competitors.

Is Shanghai Shenqi Pharmaceutical Investment Management Co's Cash per Share too high?

Shanghai Shenqi Pharmaceutical Investment Management Co's current Cash per Share is ¥1.33. Overall, Shanghai Shenqi Pharmaceutical Investment Management Co has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Shanghai Shenqi Pharmaceutical Investment Management Co's Cash per Share compare to LLY and JNJ?

Shanghai Shenqi Pharmaceutical Investment Management Co's Cash per Share of ¥1.33 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Cash per Share for a Drug Manufacturers company?

A good Cash per Share depends on the Drug Manufacturers industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Cash per Share mean?

A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Shanghai Shenqi Pharmaceutical Investment Management Co and its competitors. Shanghai Shenqi Pharmaceutical Investment Management Co's current Cash per Share is ¥1.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Shanghai Shenqi Pharmaceutical Investment Management Co stock overvalued right now?

Based on GuruFocus' analysis, Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥5.66, compared to a current price of ¥9.09 — trading 60.6% above its estimated fair value. The current Cash per Share is ¥1.33. Shanghai Shenqi Pharmaceutical Investment Management Co's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Cash per Share calculated?

Cash per Share is calculated from a company's financial statements. For Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613), the current Cash per Share is ¥1.33 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Shenqi Pharmaceutical Investment Management Co stock appears to be overvalued. The current stock price of ¥9.09 is trading 60.6% above its estimated GF Value™ of ¥5.66. GuruFocus considers Shanghai Shenqi Pharmaceutical Investment Management Co to be Significantly Overvalued.

Key valuation signals for SHSE:600613:

Cash per Share: ¥1.33
GF Value™: ¥5.66 vs. price of ¥9.09 (60.6% above fair value)
GF Score™: 49/100 with 5 warning signs

No single metric tells the full story. See the SHSE:600613 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →